background the aim of this study was to investigate whether consumption of lactobacillus plantarum heal 9 dsm 15312 and lactobacillus paracasei 87002 dsm 13434 could affect naturally acquired common cold infections in healthy subjectsmethods a randomised parallel doubleblind placebocontrolled study was performed to investigate whether intake of this probiotic mixture could reduce the risk of common cold episodes number of days with common cold symptoms frequency and severity of symptoms and cellular immune response in common cold infectionsa total of 272 subjects were supplemented daily with either 109 cfu colony forming units of probiotics n  135 or control n  137 for a 12week periodresults the incidence of acquiring one or more common cold episode was reduced from 67 in the control group to 55 in the probiotic group p  005also the number of days with common cold symptoms were significantly p  005 reduced from 86 days in the control group to 62 days in the probiotic group during the 12week periodthe total symptom score was reduced during the study period from a mean of 444 for the control group to 336 for the probiotic groupthe reduction in pharyngeal symptoms was significant p  005in addition the proliferation of b lymphocytes was significantly counteracted in the probiotic group p  005 in comparison with the control groupconclusion in conclusion intake of the probiotic strains lactobacillus plantarum heal 9 dsm 15312 and lactobacillus paracasei 87002 dsm 13434 reduces the risk of acquiring common cold infections